<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Org Biomol Chem</journal-id><journal-title-group><journal-title>Organic &#x00026; Biomolecular Chemistry</journal-title></journal-title-group><issn pub-type="ppub">1477-0520</issn><issn pub-type="epub">1477-0539</issn><publisher><publisher-name>Royal Society of Chemistry</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19194573</article-id><article-id pub-id-type="pmc">2650099</article-id><article-id pub-id-type="publisher-id">b816495a</article-id><article-id pub-id-type="doi">10.1039/b816495a</article-id><article-categories><subj-group subj-group-type="heading"><subject>Chemistry</subject></subj-group></article-categories><title-group><article-title>Identification of stable <italic>S</italic>-adenosylmethionine (SAM) analogues derivatised with bioorthogonal tags: effect of ligands on the affinity of the <italic>E. coli</italic> methionine repressor, MetJ, for its operator DNA<xref ref-type="fn" rid="fn1">&#x02020;</xref><fn id="fn1"><p>&#x02020;Electronic supplementary information (ESI) available: Experimental, NMR spectra of compounds, and materials and methods. See DOI: <uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1039/b816495a">10.1039/b816495a</uri><supplementary-material content-type="local-data" id="S1"><media xlink:href="OB-007-b816495a-s001.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></p></fn></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Joce</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="affa">a</xref><xref ref-type="aff" rid="affb">b</xref></contrib><contrib contrib-type="author"><name><surname>Caryl</surname><given-names>Jamie</given-names></name><xref ref-type="aff" rid="affb">b</xref></contrib><contrib contrib-type="author"><name><surname>Stockley</surname><given-names>Peter G.</given-names></name><xref ref-type="aff" rid="affb">b</xref></contrib><contrib contrib-type="author"><name><surname>Warriner</surname><given-names>Stuart</given-names></name><xref ref-type="aff" rid="affa">a</xref><xref ref-type="aff" rid="affb">b</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Nelson</surname><given-names>Adam</given-names></name><xref ref-type="aff" rid="affa">a</xref><xref ref-type="aff" rid="affb">b</xref></contrib></contrib-group><aff id="affa"><label>a</label> School of Chemistry, University of Leeds, Leeds, UK LS2 9JT, UK. Email: <email>a.s.nelson@leeds.ac.uk</email>; Tel: +44 (0)113 3436502</aff><aff id="affb"><label>b</label> Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK LS2 9JT</aff><pub-date pub-type="ppub"><day>21</day><month>2</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>19</day><month>12</month><year>2008</year></pub-date><volume>7</volume><issue>4</issue><fpage>635</fpage><lpage>638</lpage><history><date date-type="received"><day>22</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>8</day><month>12</month><year>2008</year></date></history><permissions><copyright-statement>This journal is &#x000a9; The Royal Society of Chemistry 2008</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/">http://creativecommons.org/licenses/by-nc/2.0/uk/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract abstract-type="toc"><p><graphic xlink:href="b816495a-ga.jpg" id="ga" position="float" orientation="portrait"/>The efficient synthesis of a range of stable SAM mimetics, and their ability to promote the binding of the <italic>E. coli</italic> methionine repressor (MetJ) to its operator DNA, is described. Active analogues functionalised with bioorthogonal tags were identified.</p></abstract><abstract><p>The efficient synthesis of a range of stable SAM mimetics, and their ability to promote the binding of the <italic>E. coli</italic> methionine repressor (MetJ) to its operator DNA, is described.</p></abstract></article-meta></front><body><p><italic>S</italic>-Adenosylmethionine or SAM, <bold>1</bold> (also known as AdoMet), is a co-factor with a wide range of biological functions, including methylation, regulation of gene expression in the bacterial methionine biosynthetic pathway, catalysis of some biological radical reactions<sup><xref ref-type="bibr" rid="cit1">1</xref>,<xref ref-type="bibr" rid="cit2">2</xref></sup> and control of a number of riboswitch elements.<sup><xref ref-type="bibr" rid="cit3">3</xref></sup> In total, SAM, <bold>1</bold>, has been identified as a ligand for fifteen protein superfamilies.<sup><xref ref-type="bibr" rid="cit1">1</xref></sup> The use of SAM, <bold>1</bold>, to study these processes has been hampered by its inherent instability.<sup><xref ref-type="bibr" rid="cit4">4</xref>,<xref ref-type="bibr" rid="cit5">5</xref></sup> Thus, stable SAM analogues, such as aza-SAM, <bold>2</bold>, which is a titratable, isostructural mimic, have been developed<sup><xref ref-type="bibr" rid="cit6">6</xref></sup> and shown to be useful tools in the analysis of SAM-dependent processes.<sup><xref ref-type="bibr" rid="cit7">7</xref>,<xref ref-type="bibr" rid="cit8">8</xref></sup></p><p>Here, we describe an improved synthesis of aza-SAM, <bold>2</bold>, which we have adapted to the preparation of a range of novel derivatives. We have also determined the ability of the analogues to promote the binding of the <italic>E. coli</italic> methionine repressor, the MetJ dimer, to its operator DNA. MetJ represses at least nine genes in the methionine biosynthetic pathway<sup><xref ref-type="bibr" rid="cit9">9</xref></sup> following activation by the non-cooperative binding of two molecules of SAM, <bold>1</bold>, which increases the affinity of MetJ for its operator DNA by a factor of 100&#x02013;1000.<sup><xref ref-type="bibr" rid="cit2">2</xref>,<xref ref-type="bibr" rid="cit8">8</xref>,<xref ref-type="bibr" rid="cit10">10</xref></sup></p><graphic xlink:href="b816495a-u1.jpg" id="ugr1" position="float" orientation="portrait"/><p>Fukuyama&#x02013;Mitsunobu reaction<sup><xref ref-type="bibr" rid="cit11">11</xref></sup> of the protected adenosine derivative<sup><xref ref-type="bibr" rid="cit12">12</xref></sup><bold>3</bold> with MeNNsH as the nucleophile gave the corresponding crystalline sulfonamide in 60% yield; deprotection gave the key amine intermediate <bold>4</bold>.<sup><xref ref-type="bibr" rid="cit13">13</xref></sup> Our approach avoided the synthesis of the 5&#x02032;-tosyl derivative of <bold>3</bold>, which was prone to cyclisation.<sup><xref ref-type="bibr" rid="cit14">14</xref></sup> Furthermore, the approach avoided the use of methylamine in a high pressure reaction vessel, which was required for conversion of the tosylate into <bold>4</bold>.<sup><xref ref-type="bibr" rid="cit15">15</xref></sup> The amine <bold>4</bold> was reacted with the mesylate <bold>6</bold>, prepared from the corresponding aspartic acid derivative,<sup><xref ref-type="bibr" rid="cit16">16</xref></sup> to give <bold>5</bold>. Deprotection gave aza-SAM, <bold>2</bold>, in 44% yield (<xref ref-type="fig" rid="sch1">Scheme 1</xref>).</p><fig id="sch1" fig-type="scheme" orientation="portrait" position="float"><label>Scheme 1</label><caption><title>Improved synthesis of aza-SAM. <italic>Conditions</italic>: (a) MeNNsH, DEAD, PPh<sub>3</sub>, THF, 18 h, 60%; (b) PhSH, Cs<sub>2</sub>CO<sub>3</sub>, MeCN, 18 h, 83%; (c) <bold>6</bold>, DIPEA, TBAI, MeCN, 65 &#x000b0;C, 13 h, 75%; (d) 2 M NaOH, MeCN, 3 h; (e) 5 M HCl, 1 h, 44% over two steps.</title></caption><graphic xlink:href="b816495a-s1"/></fig><p>The terminal carboxyl group of SAM is exposed to solvent in the structure of its complex with the MetJ dimer,<sup><xref ref-type="bibr" rid="cit2">2</xref></sup> suggesting that it may be possible to attach a bioorthogonal tag at this position (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). In addition, we wanted to explore the effect of (a) removal of the &#x003b1;-amino group in order to simplify the structure of aza-SAM; and (b) quaternisation of the 5&#x02032;-tertiary amine in order to determine the role of the charge.</p><fig id="fig1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>Identification of a position for attaching a bioorthogonal tag.</title></caption><graphic xlink:href="b816495a-f1"/></fig><p>The amide analogue <bold>7</bold> was prepared by aminolysis of the ester <bold>5</bold>, followed by removal of the protecting groups (<xref ref-type="fig" rid="sch2">Scheme 2</xref>). Similarly, alkylation of the amine <bold>4</bold> with methyl 4-iodobutyrate was followed by aminolysis with propylamine and deprotection to yield the analogue <bold>8</bold> lacking the &#x003b1;-amino group. Treatment of <bold>8</bold> with methyl iodide gave the corresponding quaternised derivative <bold>9</bold>.</p><fig id="sch2" fig-type="scheme" orientation="portrait" position="float"><label>Scheme 2</label><caption><title><italic>Conditions</italic>: (a) propylamine, 43 &#x000b0;C, 23 h, 99%; (b) 5 M HCl, 5 min, 91%; (c) methyl 4-iodobutyrate, DIPEA, MeCN, 70 &#x000b0;C, 6.5 h, 98%; (d) propylamine, 47 &#x000b0;C, 5 d, 93%; (e) TFA, 1:1 MeOH&#x02013;H<sub>2</sub>O, 5 min, 98%; (f) MeI, 3:1 MeCN&#x02013;H<sub>2</sub>O, 97%.</title></caption><graphic xlink:href="b816495a-s2"/></fig><p>Fluorescence anisotropy<sup><xref ref-type="bibr" rid="cit17">17</xref></sup> was used to measure the ability of the SAM analogues to act as co-repressors. Two 18-base oligonucleotides, one of which had a covalently-linked terminal fluorescein group, were annealed to yield the fluorescently-labelled duplex (F-<italic>metC</italic>). F-<italic>metC</italic> contained the shortest naturally occurring operator sequence for MetJ: <italic>metC.</italic><sup><xref ref-type="bibr" rid="cit18">18</xref></sup> MetJ was titrated into a solution of 10 nM F-<italic>metC</italic> in 50 mM Trizma hydrochloride pH 7.6 and 100 mM KCl, in the presence or absence of 2 mM ligand, and the increase in fluorescence anisotropy due to DNA binding was recorded (<xref ref-type="fig" rid="fig2">Fig. 2</xref>). The assay thus allowed us to determine the effect of modification of the SAM analogues on their relative ability to promote complex formation.</p><fig id="fig2" fig-type="figure" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>Cartoon illustrating the fluorescence anisotropy assay. Binding of SAM molecules promotes formation of a SAM&#x02013;<italic>F-metC</italic>&#x02013;protein complex, with two MetJ dimers bound to the 18 base-pair DNA duplex.</title></caption><graphic xlink:href="b816495a-f2"/></fig><p>Fitting the data to a sigmoidal binding model allowed extraction of the EC<sub>50</sub>, the concentration of protein required to promote half-maximal formation of the complex. Although the EC<sub>50</sub> values obtained (<xref ref-type="table" rid="tab1">Table 1</xref>) allow the relative effect of the ligands to be compared, the assay set-up may mean that the data has little physiological relevance. The EC<sub>50</sub> in the presence of 2 mM SAM, <bold>1</bold>, was 96 &#x000b1; 3 nM. In the absence of SAM, <bold>1</bold>, the affinity of MetJ for the DNA was about 30-fold lower (EC<sub>50</sub> = 2900 &#x000b1; 20 nM). The effect of SAM was smaller than previously reported estimates, which vary considerably.<sup><xref ref-type="bibr" rid="cit19">19</xref>,<xref ref-type="bibr" rid="cit20">20</xref></sup> Aza-SAM, <bold>2</bold>, was a less effective ligand than SAM, <bold>1</bold>, although it did still promote complex formation (EC<sub>50</sub> 650 &#x000b1; 40 nM). The p<italic>K</italic><sub>a</sub> of aza-SAM, <bold>2</bold>, has been shown to be 7.1<sup><xref ref-type="bibr" rid="cit8">8</xref>,<xref ref-type="bibr" rid="cit12">12</xref></sup> and so will only be around 25% protonated under the assay conditions (pH 7.6 buffer).</p><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><title>EC<sub>50</sub> values, <italic>i.e.</italic> the concentration of MetJ required to promote half-maximal formation of its complex with the F-<italic>metC</italic> DNA, in the presence and absence of ligands</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><td rowspan="1" colspan="1">Entry</td><td rowspan="1" colspan="1">Ligand<xref ref-type="table-fn" rid="tab1fna"><sup><italic>a</italic></sup></xref></td><td rowspan="1" colspan="1">EC<sub>50</sub>/nM</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">SAM, <bold>1</bold></td><td rowspan="1" colspan="1">96 &#x000b1; 3</td></tr><tr><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">aza-SAM, <bold>2</bold></td><td rowspan="1" colspan="1">650 &#x000b1; 40</td></tr><tr><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1"><bold>7</bold></td><td rowspan="1" colspan="1">910 &#x000b1; 10</td></tr><tr><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1"><bold>8</bold></td><td rowspan="1" colspan="1">1000 &#x000b1; 100</td></tr><tr><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1"><bold>9</bold></td><td rowspan="1" colspan="1">150 &#x000b1; 10</td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">no ligand</td><td rowspan="1" colspan="1">2900 &#x000b1; 20</td></tr></tbody></table><table-wrap-foot><fn id="tab1fna"><p><sup><italic>a</italic></sup>The concentration of the ligands was 2 mM.</p></fn></table-wrap-foot></table-wrap><p>The effects of the novel SAM analogues were also investigated. Replacing the carboxylic acid of aza-SAM, <bold>2</bold>, with the propyl amide of <bold>7</bold> resulted in a higher EC<sub>50</sub> (compare entry 3 with entry 2, <xref ref-type="table" rid="tab1">Table 1</xref>) though removal of the &#x003b1;-amino functionality, as in <bold>8</bold>, did not have a significant effect (entry 4). However, quaternisation of the tertiary amine of <bold>8</bold>, to give <bold>9</bold>, resulted in an EC<sub>50</sub> that was much lower than with aza-SAM, and comparable to that of SAM itself (compare entry 5 with entry 1). Thus, amide formation and removal of the &#x003b1;-amino group had a relatively small effect on ligand function. However, the charge of the amine can be deduced to be important for promoting the formation of the MetJ&#x02013;DNA complex. It was therefore decided to attach bioorthogonal tags through an amide linkage formed from the terminal carboxyl group.</p><p>With this information in hand, we prepared ligands which were functionalised with the bioorthogonal azide and cyclooctyne tags. The preparation of these analogues was, however, problematic. Alkylation of <bold>4</bold> with methyl 4-iodobutyrate was followed by ester hydrolysis and amide formation with ethanolamine to yield the amide <bold>10</bold> (<xref ref-type="fig" rid="sch3">Scheme 3)</xref>. Activation of <bold>10</bold> by treatment with methanesulfonic anhydride, however, triggered cyclisation to yield the corresponding oxazoline; nonetheless, this intermediate could be opened to yield the required azide <bold>11</bold> (yield: 56% from <bold>10</bold>). Similarly, coupling with 2-(cyclooct-2-ynoxy)-ethylamine did give the required amide; however attempted deprotection resulted in hydration of the strained alkyne. We therefore decided to delay the formation of the cyclooctyne until after deprotection of the ligand. Thus, 2-((<italic>Z</italic>)-2-bromocyclooct-2-enyloxy) ethylamine was reacted to yield the amide <bold>13</bold>; after removal of the acetonide protecting group, treatment with five equivalents of sodium hydride in THF&#x02013;DMF resulted in elimination to give the required cyclooctyne <bold>14</bold> in 95% yield. Remarkably, under these conditions, the elimination proceeded more smoothly than has been previously reported<sup><xref ref-type="bibr" rid="cit21">21</xref></sup> and clean elimination was possible in the presence of five potentially acidic protons. Treatment of the tagged analogues <bold>12</bold> and <bold>14</bold> with methyl iodide yielded the corresponding quaternised derivatives <bold>15</bold> and <bold>16</bold>.</p><fig id="sch3" fig-type="scheme" orientation="portrait" position="float"><label>Scheme 3</label><caption><title><italic>Conditions</italic>: (a) methyl 4-iodobutyrate, DIPEA, MeCN, 70 &#x000b0;C, 6.5 h, 98%; (b) NaOH, MeOH, 2 d, 57%; c) ethanolamine, PyBOP, DIPEA, DMF, 30 min, 93%; (d) Ms<sub>2</sub>O, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 &#x000b0;C, 30 min then NaN<sub>3</sub>, DMSO, 70 &#x000b0;C, 2 h, 56%; (e), 5 M HCl, 20 min, 94%; (f) 2-((<italic>Z</italic>)-2-bromocyclooct-2-enyloxy) ethylamine, PyBOP, DIPEA, DMF, 30 min, 80%; (g) 5 M HCl, 6 min, 75%; (h) NaH, 1:1 DMF&#x02013;THF, 30 min, 95%; (i) MeI, 3:1 MeCN&#x02013;H<sub>2</sub>O, <bold>15</bold>: 88%, <bold>16</bold>: 86%.</title></caption><graphic xlink:href="b816495a-s3"/></fig><p>The ability of the tagged analogues to promote the binding of MetJ dimer to DNA was also investigated using fluorescence anisotropy. The assay allowed us to determine the effect of attachment of the bioorthogonal tags on the activity of the SAM analogues. Both tagged analogues <bold>12</bold> and <bold>14</bold> were more efficient at binding to MetJ than the model propyl amide <bold>8</bold> (compare entry 4, <xref ref-type="table" rid="tab1">Table 1</xref> with entries 3 and 4, <xref ref-type="table" rid="tab2">Table 2</xref>). Once more, however, quaternised analogues were significantly more effective than the corresponding uncharged derivatives (compare entries 5 and 6, with entries 3 and 4, <xref ref-type="table" rid="tab2">Table 2</xref>). The most potent compound was the quaternised analogue, <bold>16</bold>, that had been derivatised with the cyclooctyne tag. Furthermore, <bold>16</bold> was a more effective ligand than SAM itself (EC<sub>50</sub> 96 &#x000b1; 3 nM).</p><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><title>EC<sub>50</sub> values, <italic>i.e.</italic> the concentration of MetJ required to promote half-maximal formation of its complex with the F-<italic>metC</italic> DNA, in the presence and absence of ligands</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><td rowspan="1" colspan="1">Entry</td><td rowspan="1" colspan="1">Ligand<xref ref-type="table-fn" rid="tab2fna"><sup><italic>a</italic></sup></xref></td><td rowspan="1" colspan="1">EC<sub>50</sub>/nM</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">SAM, <bold>1</bold></td><td rowspan="1" colspan="1">96 &#x000b1; 3</td></tr><tr><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">aza-SAM, <bold>2</bold></td><td rowspan="1" colspan="1">650 &#x000b1; 40</td></tr><tr><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1"><bold>12</bold></td><td rowspan="1" colspan="1">540 &#x000b1; 20</td></tr><tr><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1"><bold>14</bold></td><td rowspan="1" colspan="1">650 &#x000b1; 40</td></tr><tr><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1"><bold>15</bold></td><td rowspan="1" colspan="1">154 &#x000b1; 6</td></tr><tr><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1"><bold>16</bold></td><td rowspan="1" colspan="1">65 &#x000b1; 3</td></tr><tr><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">no ligand</td><td rowspan="1" colspan="1">2900 &#x000b1; 20</td></tr></tbody></table><table-wrap-foot><fn id="tab2fna"><p><sup><italic>a</italic></sup>The concentration of the ligands was 2 mM.</p></fn></table-wrap-foot></table-wrap><p>In summary, we have described an improved synthesis of aza-SAM which we have adapted to the synthesis of a range of other stable analogues of the co-factor SAM. We have investigated the ability of these analogues to promote the binding of the MetJ dimer to its DNA operator. In particular, we have shown that quaternisation enhances the activity of aza-SAM analogues, and that it is possible to append a bioorthogonal tag through conversion of the terminal carboxyl group into an amide. SAM analogues which have been derivatised with a bioorthogonal tag may be useful chemical tools for isolating, identifying and modulating other SAM-binding macromolecules such as methyltransferases, fluorinases, radical SAM proteins and riboswitch domains.</p></body><back><ack><p>We thank the Wellcome Trust, EPSRC and BBSRC for funding, and Dr Bruce Turnbull for discussions.</p></ack><ref-list><ref id="cit1"><element-citation publication-type="journal"><person-group><name><surname>Loenen</surname><given-names>W. A. M.</given-names></name></person-group><source>Biochem. Soc. Trans.</source><year>2006</year><volume>34</volume><fpage>330</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">16545107</pub-id></element-citation></ref><ref id="cit2"><element-citation publication-type="journal"><person-group><name><surname>Rafferty</surname><given-names>J. B.</given-names></name><name><surname>Somers</surname><given-names>W. S.</given-names></name><name><surname>Saint-Girons</surname><given-names>I.</given-names></name><name><surname>Phillips</surname><given-names>S. E. V.</given-names></name></person-group><source>Nature</source><year>1989</year><volume>341</volume><fpage>705</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">2677753</pub-id></element-citation></ref><ref id="cit3"><element-citation publication-type="journal"><person-group><name><surname>Gilbert</surname><given-names>S. D.</given-names></name><name><surname>Rambo</surname><given-names>R. P.</given-names></name><name><surname>Van Tyne</surname><given-names>D.</given-names></name><name><surname>Batey</surname><given-names>R. T.</given-names></name></person-group><source>Nat. Struct. Mol. Biol.</source><year>2008</year><volume>15</volume><fpage>177</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">18204466</pub-id></element-citation></ref><ref id="cit4"><mixed-citation publication-type="thesis"><name><surname>Knowles</surname><given-names>T. J.</given-names></name>, PhD Thesis, University of Leeds, <year>2005</year></mixed-citation></ref><ref id="cit5"><element-citation publication-type="journal"><person-group><name><surname>Desiderio</surname><given-names>C.</given-names></name><name><surname>Cavallaro</surname><given-names>R. A.</given-names></name><name><surname>De Rossi</surname><given-names>A.</given-names></name><name><surname>D'Anselmi</surname><given-names>F.</given-names></name><name><surname>Fuso</surname><given-names>A.</given-names></name><name><surname>Scarpa</surname><given-names>S.</given-names></name></person-group><source>J. Pharm. Biomed. Anal.</source><year>2005</year><volume>38</volume><fpage>449</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">15925246</pub-id></element-citation></ref><ref id="cit6"><element-citation publication-type="journal"><person-group><name><surname>Thompson</surname><given-names>M. J.</given-names></name><name><surname>Mekhalfia</surname><given-names>A.</given-names></name><name><surname>Jakeman</surname><given-names>D. L.</given-names></name><name><surname>Phillips</surname><given-names>S. E. V.</given-names></name><name><surname>Phillips</surname><given-names>K.</given-names></name><name><surname>Porter</surname><given-names>J.</given-names></name><name><surname>Blackburn</surname><given-names>G. M.</given-names></name></person-group><source>Chem. Commun.</source><year>1996</year><fpage>791</fpage><lpage>792</lpage></element-citation></ref><ref id="cit7"><element-citation publication-type="journal"><person-group><name><surname>Couture</surname><given-names>J.-F.</given-names></name><name><surname>Hauk</surname><given-names>G.</given-names></name><name><surname>Thompson</surname><given-names>M. J.</given-names></name><name><surname>Blackburn</surname><given-names>G. M.</given-names></name><name><surname>Trievel</surname><given-names>R. C.</given-names></name></person-group><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>19280</fpage><lpage>19287</lpage><pub-id pub-id-type="pmid">16682405</pub-id></element-citation></ref><ref id="cit8"><element-citation publication-type="journal"><person-group><name><surname>Parsons</surname><given-names>I. D.</given-names></name><name><surname>Persson</surname><given-names>B.</given-names></name><name><surname>Mekhalfia</surname><given-names>A.</given-names></name><name><surname>Blackburn</surname><given-names>G. M.</given-names></name><name><surname>Stockley</surname><given-names>P. G.</given-names></name></person-group><source>Nucleic Acids Res.</source><year>1995</year><volume>23</volume><fpage>211</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">7862523</pub-id></element-citation></ref><ref id="cit9"><element-citation publication-type="journal"><person-group><name><surname>Marincs</surname><given-names>F.</given-names></name><name><surname>Manfield</surname><given-names>I. W.</given-names></name><name><surname>Stead</surname><given-names>J. A.</given-names></name><name><surname>McDowall</surname><given-names>K. J.</given-names></name><name><surname>Stockley</surname><given-names>P. G.</given-names></name></person-group><source>Biochem. J.</source><year>2006</year><volume>396</volume><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">16515535</pub-id></element-citation></ref><ref id="cit10"><element-citation publication-type="journal"><person-group><name><surname>Cooper</surname><given-names>A.</given-names></name><name><surname>McAlpine</surname><given-names>A.</given-names></name><name><surname>Stockley</surname><given-names>P. G.</given-names></name></person-group><source>FEBS Lett.</source><year>1994</year><volume>348</volume><fpage>41</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">8026581</pub-id></element-citation></ref><ref id="cit11"><element-citation publication-type="journal"><person-group><name><surname>Fukuyama</surname><given-names>T.</given-names></name><name><surname>Jow</surname><given-names>C.-K.</given-names></name><name><surname>Cheung</surname><given-names>M.</given-names></name></person-group><source>Tetrahedron Lett.</source><year>1995</year><volume>36</volume><fpage>6373</fpage><lpage>6374</lpage></element-citation></ref><ref id="cit12"><element-citation publication-type="journal"><person-group><name><surname>Thompson</surname><given-names>M. J.</given-names></name><name><surname>Mekhalfia</surname><given-names>A.</given-names></name><name><surname>Hornby</surname><given-names>D. P.</given-names></name><name><surname>Blackburn</surname><given-names>G. M.</given-names></name></person-group><source>J. Org. Chem.</source><year>1999</year><volume>64</volume><fpage>7467</fpage><lpage>7473</lpage></element-citation></ref><ref id="cit13"><element-citation publication-type="journal"><person-group><name><surname>Jastorff</surname><given-names>B.</given-names></name><name><surname>Murayama</surname><given-names>A.</given-names></name><name><surname>Cramer</surname><given-names>F.</given-names></name><name><surname>Hettler</surname><given-names>H.</given-names></name></person-group><source>J. Org. Chem.</source><year>1971</year><volume>36</volume><fpage>3029</fpage><lpage>3033</lpage><pub-id pub-id-type="pmid">4330928</pub-id></element-citation></ref><ref id="cit14"><element-citation publication-type="journal"><person-group><name><surname>Clark</surname><given-names>V. M.</given-names></name><name><surname>Todd</surname><given-names>A. R.</given-names></name><name><surname>Zussman</surname><given-names>J.</given-names></name></person-group><source>J. Chem. Soc.</source><year>1951</year><fpage>2952</fpage><lpage>2958</lpage></element-citation></ref><ref id="cit15"><element-citation publication-type="journal"><person-group><name><surname>Minnick</surname><given-names>A. A.</given-names></name><name><surname>Kenyon</surname><given-names>G. L.</given-names></name></person-group><source>J. Org. Chem.</source><year>1988</year><volume>53</volume><fpage>4952</fpage><lpage>4961</lpage></element-citation></ref><ref id="cit16"><element-citation publication-type="journal"><person-group><name><surname>Broadrup</surname><given-names>R. L.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Malachowski</surname><given-names>W. P.</given-names></name></person-group><source>Tetrahedron</source><year>2005</year><volume>61</volume><fpage>10277</fpage><lpage>10284</lpage></element-citation></ref><ref id="cit17"><element-citation publication-type="journal"><person-group><name><surname>Jameson</surname><given-names>D. M.</given-names></name><name><surname>Sawyer</surname><given-names>W. H.</given-names></name></person-group><source>Methods Enzymol.</source><year>1995</year><volume>246</volume><fpage>283</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">7752928</pub-id></element-citation></ref><ref id="cit18"><element-citation publication-type="journal"><person-group><name><surname>Belfaiza</surname><given-names>J.</given-names></name><name><surname>Parsot</surname><given-names>C.</given-names></name><name><surname>Martel</surname><given-names>A.</given-names></name><name><surname>de la Tour</surname><given-names>C. Bouthier</given-names></name><name><surname>Margarita</surname><given-names>D.</given-names></name><name><surname>Cohen</surname><given-names>G. N.</given-names></name><name><surname>Saint-Girons</surname><given-names>I.</given-names></name></person-group><source>Proc. Natl. Acad. Sci. U. S. A</source><year>1986</year><volume>83</volume><fpage>867</fpage><lpage>871</lpage><pub-id pub-id-type="pmid">3513164</pub-id></element-citation></ref><ref id="cit19"><element-citation publication-type="journal"><person-group><name><surname>Phillips</surname><given-names>S. E. V.</given-names></name><name><surname>Manfield</surname><given-names>I.</given-names></name><name><surname>Parsons</surname><given-names>I.</given-names></name><name><surname>Davidson</surname><given-names>B. E.</given-names></name><name><surname>Rafferty</surname><given-names>J. B.</given-names></name><name><surname>Somers</surname><given-names>W. S.</given-names></name><name><surname>Margarita</surname><given-names>D.</given-names></name><name><surname>Cohen</surname><given-names>G. N.</given-names></name><name><surname>Saint-Girons</surname><given-names>I.</given-names></name><name><surname>Stockley</surname><given-names>P. G.</given-names></name></person-group><source>Nature</source><year>1989</year><volume>341</volume><fpage>711</fpage><lpage>715</lpage><pub-id pub-id-type="pmid">2677754</pub-id></element-citation></ref><ref id="cit20"><element-citation publication-type="journal"><person-group><name><surname>Phillips</surname><given-names>K.</given-names></name><name><surname>Phillips</surname><given-names>S. E. V.</given-names></name></person-group><source>Structure</source><year>1994</year><volume>2</volume><fpage>309</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">8087557</pub-id></element-citation></ref><ref id="cit21"><element-citation publication-type="journal"><person-group><name><surname>Agard</surname><given-names>N. J.</given-names></name><name><surname>Prescher</surname><given-names>J. A.</given-names></name><name><surname>Bertozzi</surname><given-names>C. R.</given-names></name></person-group><source>J. Am. Chem. Soc.</source><year>2004</year><volume>126</volume><fpage>15046</fpage><lpage>15047</lpage><pub-id pub-id-type="pmid">15547999</pub-id></element-citation></ref></ref-list></back></article>